M. Glennie and P. Johnson, Clinical trials of antibody therapy, Immunology Today, vol.21, issue.8, pp.403-410, 2000.
DOI : 10.1016/S0167-5699(00)01669-8

T. Gura, Therapeutic antibodies: Magic bullets hit the target, Nature, vol.14, issue.6889, pp.584-586, 2002.
DOI : 10.1073/PNAS.98.4.1799

M. Pelegrin, L. Gros, H. Dreja, and M. Piechaczyk, Monoclonal antibodybased immunotherapies, Current gene therapy, 2004.

D. Noel, M. Pelegrin, M. Marin, P. Biard, J. Ourlin et al., Secretion of Cloned Antibodies by Genetically Modified Myogenic Cells, Human Gene Therapy, vol.8, issue.10, pp.1219-1229, 1997.
DOI : 10.1089/hum.1997.8.10-1219

D. Noel, M. Pelegrin, F. Brockly, A. Lund, and M. Piechaczyk, Sustained Systemic Delivery of Monoclonal Antibodies by Genetically Modified Skin Fibroblasts, Journal of Investigative Dermatology, vol.115, issue.4, pp.740-745, 2000.
DOI : 10.1046/j.1523-1747.2000.00106.x

D. Noel, J. Dazard, M. Pelegrin, C. Jacquet, and M. Piechaczyk, Skin as a Potential Organ for Ectopic Monoclonal Antibody Production11The authors declared not to have a conflict of interest., Journal of Investigative Dermatology, vol.118, issue.2, pp.288-294, 2002.
DOI : 10.1046/j.0022-202x.2001.01625.x

D. Noel, M. Pelegrin, S. Kramer, C. Jacquet, N. Skander et al., Production of a Model Monoclonal Antibody on Adenoviral Gene Transfer, Human Gene Therapy, vol.13, issue.12, pp.1483-1493, 2002.
DOI : 10.1089/10430340260185111

A. Lewis, R. Chen, D. Montefiori, P. Johnson, and K. Clark, Generation of Neutralizing Activity against Human Immunodeficiency Virus Type 1 in Serum by Antibody Gene Transfer, Journal of Virology, vol.76, issue.17, pp.8769-8775, 2002.
DOI : 10.1128/JVI.76.17.8769-8775.2002

M. Pelegrin, M. Marin, D. Noël, D. Rio, M. Saller et al., Systemic long-term delivery of antibodies in immunocompetent animals using cellulose sulphate capsules containing antibody-producing cells, Gene Therapy, vol.5, issue.6, pp.828-834, 1998.
DOI : 10.1038/sj.gt.3300632

M. Pelegrin, M. Marin, A. Oates, D. Noel, R. Saller et al., Production of Therapeutic Monoclonal Antibodies, Human Gene Therapy, vol.11, issue.10, pp.1407-1415, 2000.
DOI : 10.1089/10430340050057486

E. Ilan, J. Arazi, O. Nussbaum, A. Zauberman, R. Eren et al., The Hepatitis C Virus (HCV)???Trimera Mouse: A Model for Evaluation of Agents against HCV, The Journal of Infectious Diseases, vol.185, issue.2, pp.153-161, 2002.
DOI : 10.1086/338266

G. Stiegler, C. Armbruster, B. Vcelar, H. Stoiber, R. Kunert et al., Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans, AIDS, vol.16, issue.15, pp.2019-2025, 2002.
DOI : 10.1097/00002030-200210180-00006

H. Aihara and J. Miyazaki, Gene transfer into muscle by electroporation in vivo, Nature Biotechnology, vol.3, issue.9, pp.867-870, 1998.
DOI : 10.1016/0378-1119(91)90434-D

L. Mir, M. Bureau, J. Gehl, R. Rangara, D. Rouy et al., High-efficiency gene transfer into skeletal muscle mediated by electric pulses, Proceedings of the National Academy of Sciences, vol.63, issue.5, pp.4262-4267, 1999.
DOI : 10.1016/S0006-3495(92)81709-5

P. Bigey, M. Bureau, and D. Scherman, In vivo plasmid DNA electrotransfer, Current Opinion in Biotechnology, vol.13, issue.5, pp.443-447, 2002.
DOI : 10.1016/S0958-1669(02)00377-4

D. Scherman, Towards non-viral gene therapy], Bull Acad Natl Med, vol.185, pp.1683-1697, 2001.

V. Klenchin, S. Sukharev, S. Serov, and L. Chernomordik, Electrically induced DNA uptake by cells is a fast process involving DNA electrophoresis, Biophysical Journal, vol.60, issue.4, pp.804-811, 1991.
DOI : 10.1016/S0006-3495(91)82115-4

M. Bureau, J. Gehl, V. Deleuze, L. Mir, and D. Scherman, Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1474, issue.3, pp.353-359, 2000.
DOI : 10.1016/S0304-4165(00)00028-3

M. Golzio, J. Teissie, and M. Rols, Direct visualization at the single-cell level of electrically mediated gene delivery, Proceedings of the National Academy of Sciences, vol.70, issue.3, pp.1292-1297, 2002.
DOI : 10.1016/S0009-3084(99)00060-2

D. Noel, T. Bernardi, I. Navarro-teulon, M. Marin, J. Martinetto et al., Analysis of the individual contributions of immunoglobulin heavy and light chains to the binding of antigen using cell transfection and plasmon resonance analysis, Journal of Immunological Methods, vol.193, issue.2, pp.177-187, 1996.
DOI : 10.1016/0022-1759(96)00043-9

F. Soubrier, B. Cameron, B. Manse, S. Somarriba, C. Dubertret et al., pCOR: a new design of plasmid vectors for nonviral gene therapy, Gene Therapy, vol.6, issue.8, pp.1482-1488, 1999.
DOI : 10.1038/sj.gt.3300968

M. Gossen and H. Bujard, Studying Gene Function in Eukaryotes by Conditional Gene Inactivation, Annual Review of Genetics, vol.36, issue.1, pp.153-173, 2002.
DOI : 10.1146/annurev.genet.36.041002.120114

M. Gossen and H. Bujard, Tight control of gene expression in mammalian cells by tetracycline-responsive promoters., Proceedings of the National Academy of Sciences, vol.89, issue.12, pp.5547-5551, 1992.
DOI : 10.1073/pnas.89.12.5547

H. Garmory, K. Brown, and R. Titball, DNA vaccines: improving expression of antigens, Genet Vaccines Ther, vol.1, issue.2, 2003.

C. Bloquel, E. Fabre, M. Bureau, and D. Scherman, Plasmid DNA electrotransfer for intracellular and secreted proteins expression: new methodological developments and applications, The Journal of Gene Medicine, vol.6, issue.S1, pp.11-23, 2004.
DOI : 10.1002/jgm.508

P. Loser, G. Jennings, M. Strauss, and V. Sandig, Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB, J Virol, vol.72, pp.180-190, 1998.

R. Bartlett, S. Secore, J. Singer, M. Bodo, K. Sharma et al., Long-term expression of a fluorescent reporter gene via direct injection of plasmid vector into mouse skeletal muscle: Comparison of human creatine kinase and CMV promoter expression levels in vivo, Cell Transplantation, vol.5, issue.3, pp.411-419, 1996.
DOI : 10.1016/0963-6897(95)02026-8

D. Loirat, Z. Li, M. Mancini, P. Tiollais, D. Paulin et al., Muscle-Specific Expression of Hepatitis B Surface Antigen: No Effect on DNA-Raised Immune Responses, Virology, vol.260, issue.1, pp.74-83, 1999.
DOI : 10.1006/viro.1999.9795

X. Li, E. Eastman, R. Schwartz, and R. Draghia-akli, Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences, Nat Biotechnol, vol.17, pp.241-245, 1999.

D. Favre, V. Blouin, N. Provost, R. Spisek, F. Porrot et al., Lack of an Immune Response against the Tetracycline-Dependent Transactivator Correlates with Long-Term Doxycycline-Regulated Transgene Expression in Nonhuman Primates after Intramuscular Injection of Recombinant Adeno-Associated Virus, Journal of Virology, vol.76, issue.22, pp.11605-11611, 2002.
DOI : 10.1128/JVI.76.22.11605-11611.2002

D. Bohl, N. Naffakh, and J. Heard, Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts, Nature Medicine, vol.70, issue.3, pp.299-305, 1997.
DOI : 10.1016/0092-8674(81)90343-3

D. Bohl and J. Heard, Modulation of Erythropoietin Delivery from Engineered Muscles in Mice, Human Gene Therapy, vol.8, issue.2, pp.195-204, 1997.
DOI : 10.1089/hum.1997.8.2-195

D. Bohl, A. Salvetti, P. Moullier, and J. Heard, Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector, Blood, vol.92, pp.1512-1517, 1998.